Identification Generic Name (1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL DrugBank Accession Number DB08649 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL (DB08649) ×  Close Weight Average: 176.2151  Monoisotopic: 176.094963016  Chemical Formula C 10 H 12 N 2 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Aralkylamine dehydrogenase light chain Not Available Alcaligenes faecalis U Aralkylamine dehydrogenase heavy chain Not Available Alcaligenes faecalis Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Indoles and derivatives Sub Class Indoles Direct Parent 3-alkylindoles Alternative Parents Substituted pyrroles  /  Benzenoids  /  Heteroaromatic compounds  /  Hemiaminals  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organooxygen compounds  /  Monoalkylamines  /  Hydrocarbon derivatives Substituents 3-alkylindole  /  Alkanolamine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Hemiaminal  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Organic nitrogen compound  /  Organic oxygen compound Molecular Framework Aromatic heteropolycyclic compounds External Descriptors tryptamines ( CHEBI:46144 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key WNWJSYYPDDQIQV-JTQLQIEISA-N InChI InChI=1S/C10H12N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,10,12-13H,5,11H2/t10-/m0/s1 IUPAC Name (1S)-1-amino-2-(1H-indol-3-yl)ethan-1-ol SMILES [H][C@](N)(O)CC1=CNC2=CC=CC=C12 References General References Not Available External Links PubChem Compound 20846113 PubChem Substance 99445120 ChemSpider 20163058 ChEBI 46144 ZINC ZINC000053683275 PDBe Ligand TSC PDB Entries 2agz  /  2ah0 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 5.89 mg/mL ALOGPS logP 0.72 ALOGPS logP 0.89 Chemaxon logS -1.5 ALOGPS pKa (Strongest Acidic) 14.15 Chemaxon pKa (Strongest Basic) 8.92 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 62.04 Å 2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 51.51 m 3 ·mol -1 Chemaxon Polarizability 18.93 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9796 Blood Brain Barrier + 0.9928 Caco-2 permeable - 0.621 P-glycoprotein substrate Non-substrate 0.6647 P-glycoprotein inhibitor I Non-inhibitor 0.986 P-glycoprotein inhibitor II Non-inhibitor 0.9758 Renal organic cation transporter Non-inhibitor 0.8156 CYP450 2C9 substrate Non-substrate 0.8234 CYP450 2D6 substrate Non-substrate 0.7657 CYP450 3A4 substrate Non-substrate 0.7106 CYP450 1A2 substrate Non-inhibitor 0.8174 CYP450 2C9 inhibitor Non-inhibitor 0.8323 CYP450 2D6 inhibitor Non-inhibitor 0.7175 CYP450 2C19 inhibitor Non-inhibitor 0.858 CYP450 3A4 inhibitor Non-inhibitor 0.8586 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7914 Ames test Non AMES toxic 0.8888 Carcinogenicity Non-carcinogens 0.9081 Biodegradation Not ready biodegradable 0.9321 Rat acute toxicity 1.8404 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.993 hERG inhibition (predictor II) Non-inhibitor 0.9167    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Aralkylamine dehydrogenase light chain Kind Protein Organism Alcaligenes faecalis Pharmacological action Unknown General Function Aralkylamine dehydrogenase (azurin) activity Specific Function Oxidizes primary aromatic amines and, more slowly, some long-chain aliphatic amines, but not methylamine or ethylamine. Uses azurin as an electron acceptor to transfer electrons from the reduced tr... Gene Name aauA Uniprot ID P84887 Uniprot Name Aralkylamine dehydrogenase light chain Molecular Weight 19651.915 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  Aralkylamine dehydrogenase heavy chain Kind Protein Organism Alcaligenes faecalis Pharmacological action Unknown General Function Aralkylamine dehydrogenase (azurin) activity Specific Function Oxidizes primary aromatic amines and, more slowly, some long-chain aliphatic amines, but not methylamine or ethylamine. Uses azurin as an electron acceptor to transfer electrons from the reduced tr... Gene Name aauB Uniprot ID P84888 Uniprot Name Aralkylamine dehydrogenase heavy chain Molecular Weight 42924.595 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:33 / Updated at June 12, 2020 16:52 